Democratizing Precision in Cataract Surgery with ArcDUO for Astigmatism Correction
Overview
The ArcDUO device offers a novel, cost-effective approach to corneal astigmatism correction during and after cataract surgery. Early retrospective data demonstrate promising reductions in astigmatism and good visual outcomes with a simple, low-learning-curve technique.
Background
Astigmatism management in cataract surgery requires balancing corneal astigmatism magnitude, intraocular lens compensation, patient ocular health, and economic factors. Femtosecond laser-assisted cataract surgery (FLACS) improves precision in limbal relaxing incisions (LRIs) but is costly and not universally accessible. Manual LRIs are affordable but less predictable and require significant surgical skill. There is a need for an intermediate solution that combines accuracy with affordability and ease of use.
Data Highlights
Parameter
Value/Range
Preoperative Astigmatism
0.59 to 1.67 D (mean ~0.84 D)
Postoperative Astigmatism
Mean 0 D at day 1, week 1, and month 1 (variable subsets)
Mean Best-Corrected Visual Acuity (BCVA)
20/22 at 1 week (n=36) and 1 month (n=21)
Follow-up Duration
Up to 1 month (early postoperative phase)
Sample Size
Variable, small cohorts with incomplete follow-up
Key Findings
ArcDUO enables controlled-depth, paired arcuate corneal incisions with guide templates for multiple arc lengths (15°, 30°, 45°, 60°) and diameters (9 mm, 10 mm).
The device is simple to use, with a short learning curve and does not typically require anesthesia during outpatient postoperative procedures.
Early retrospective data show mean postoperative astigmatism reduced to zero across multiple early timepoints despite small sample sizes.
Patients achieved good visual acuity (mean BCVA 20/22) and reported high satisfaction without adverse events or corneal perforations.
ArcDUO allows treatment of low-level astigmatism (<0.5 D), important for optimizing outcomes with advanced technology intraocular lenses.
Incisions can be reopened if needed, providing flexibility in managing regression or residual astigmatism.
Clinical Implications
ArcDUO offers a practical middle ground between manual LRIs and expensive femtosecond laser approaches, enabling precise astigmatism correction with affordability and ease. Its use in both perioperative and postoperative settings allows clinicians to address residual or newly developed astigmatism without returning to the operating room. This may improve patient satisfaction, especially for those receiving multifocal IOLs where even minimal residual astigmatism impacts visual quality.
Conclusion
ArcDUO represents an innovative, accessible tool for enhancing precision in cataract surgery astigmatism management. While early results are promising, further prospective studies with larger cohorts and longer follow-up are needed to confirm its long-term efficacy and stability.
References
Author/Source/2024 -- Democratizing Precision in Cataract Surgery
At the Outpatient Ophthalmic Surgery Society’s “OOSS Perspective 2026” symposium in Washington, DC, the organization's Washington counsel, Michael Romansky, JD, delivered an update on reimbursement, regulatory developments, and advocacy priorities affecting ophthalmic ambulatory surgery centers (ASCs).
